Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 4 (2007), Issue 9 (September)

1. Monitoring brain tissue oxymetry: will it change management of critically ill neurologic patients?
   J Neurol Sci, 261(1): 1-9. [Abstract] [Full-text]
2. Hyperventilation-induced nystagmus in peripheral vestibulopathy and cerebellopontine angle tumor.
   Neurology, 69(10): 1050-9. [Abstract] [Full-text]
3. Development of bionanocapsules targeting brain tumors.
   J Control Release, 122(2): 159-64. [Abstract] [Full-text]
4. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
   Cancer, 110(6): 1345-50. [Abstract] [Full-text]
5. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
   Cancer, 110(6): 1329-37. [Abstract] [Full-text]
6. Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
   Neurology, 69(11): 1178-82. [Abstract] [Full-text]
7. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells.
   Biochem Biophys Res Commun, 362(3): 612-8. [Abstract] [Full-text]
8. Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis.
   Biochem Biophys Res Commun, 362(3): 747-52. [Abstract] [Full-text]
9. O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines.
   Cancer Chemother Pharmacol, 60(6): 883-9. [Abstract] [Full-text]
10. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
    Cancer Gene Ther, 14(10): 836-46. [Abstract] [Full-text]
11. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.
    Int J Radiat Oncol Biol Phys, 69(2): 589-97. [Abstract] [Full-text]
12. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Int J Radiat Oncol Biol Phys, 69(2): 404-10. [Abstract] [Full-text]
13. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Int J Radiat Oncol Biol Phys, 69(2): 381-9. [Abstract] [Full-text]
14. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Int J Radiat Oncol Biol Phys, 69(2): 390-6. [Abstract] [Full-text]
15. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.
    J Natl Cancer Inst, 99(18): 1410-4. [Abstract] [Full-text]
16. Temozolomide in pediatric low-grade glioma.
    Pediatr Blood Cancer, 49(6): 808-11. [Abstract] [Full-text]
17. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
    J Control Release, 122(3): 356-63. [Abstract] [Full-text]
18. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.
    J Control Release, 122(3): 315-23. [Abstract] [Full-text]
19. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
    J Surg Res, 142(2): 268-74. [Abstract] [Full-text]
20. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus.
    Glia, 55(15): 1554-64. [Abstract] [Full-text]
21. Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.
    Neurology, 69(13): 1366-73. [Abstract] [Full-text]
22. Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors.
    J Neurosurg Anesthesiol, 19(4): 239-42. [Abstract] [Full-text]
23. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Cancer, 110(7): 1542-50. [Abstract] [Full-text]
24. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Cancer, 110(7): 1551-9. [Abstract] [Full-text]
25. CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation.
    Nat Clin Pract Oncol, 4(10): 603-7. [Abstract] [Full-text]
26. Long-term survival with glioblastoma multiforme.
    Brain, 130: 2596-606. [Abstract] [Full-text]
27. Allergic conditions and brain tumor risk.
    Am J Epidemiol, 166(8): 941-50. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.